Jim Cramer explains that Federal Reserve rate hikes cause market sell-offs, creating opportunities to buy dividend stocks at discounts. He distinguishes between 'accidental high yielders'—stocks with high yields due to price drops but solid fundamentals—and 'yield traps' with risky payouts. Key tests include why yields rose, dividend coverage by earnings and cash flow, and manageable debt levels. Examples like Verizon and T. Rowe Price illustrate these points. The next Fed meeting will test if the market bounce occurs once tightening ends.
Jim Cramer's discussion on 'accidental high yielders' like Verizon and T. Rowe Price highlights stocks that may attract attention during Fed-induced market shifts. On Pluang as of Oct 25, 2026 01:11 WIB, Verizon trades at USD 44.66 with a dividend yield of 6.34% but shows a 1-day decline of 1.19% amid heavy selling activity (99% sell orders). Meanwhile, T. Rowe Price is priced at USD 104.20, up 0.72% on the day, offering a 4.99% dividend yield. These figures illustrate how market dynamics impact investor behavior on the platform.
Citi projects SpaceX's Starlink will not launch a national wireless service until around 2029, positioning it behind established telecom giants like AT&T and Verizon. However, recent reports that SpaceX aims to secure 80,000 cell sites across the US ...
Verizon and AT&T both raised guidance recently, but their dividend strategies differ sharply. Verizon increased its quarterly dividend to $0.7075, offering a forward yield of 6.26% and maintaining a 19-year streak of annual raises, which helps retire...
Shares of T-Mobile, AT&T, and Verizon fell sharply after reports that SpaceX is negotiating access to 80,000 U.S. cell sites, aiming to become a fourth national wireless carrier. This move would combine SpaceX's satellite service with terrestrial inf...
SpaceX is reportedly negotiating access to about 80,000 U.S. cell towers to establish a fourth nationwide wireless carrier, potentially disrupting the telecom market. While major carriers like Verizon, AT&T, and T-Mobile saw stock declines, tower own...
Moderna's shares fell nearly 18% after positive Phase 3 results for its personalized melanoma vaccine with Merck were leaked early, causing market uncertainty despite the promising data. Meanwhile, SpaceX is negotiating with major infrastructure firm...
